Company Filing History:
Years Active: 2025
Title: Innovations of Rahul Purwar in Immunotherapy
Introduction
Rahul Purwar is a notable inventor based in Mumbai, India. He has made significant contributions to the field of immunotherapy through his innovative research and development. His work focuses on the creation of advanced therapeutic solutions for diseases associated with the expression of the Cluster of Differentiation 19 protein (CD19).
Latest Patents
One of Rahul Purwar's key patents is titled "Humanized anti-CD19 chimeric antigen receptor, its nucleic acid sequence and its preparation." This invention relates to a novel humanized anti-CD19 chimeric antigen receptor that contains an optimized anti-CD19 binding domain. It is designed to be effective in treating diseases linked to CD19 expression. The patent also includes a nucleic acid molecule encoding the humanized CAR, along with a process for its preparation, compositions containing the CAR, vectors with the polynucleotide encoding the CAR, and cells expressing the CAR on their surface. This innovation holds great promise for enhancing immunotherapy treatments.
Career Highlights
Rahul Purwar is affiliated with the Indian Institute of Technology Bombay, where he continues to advance his research in the field of immunotherapy. His dedication to innovation has led to the development of groundbreaking technologies that can potentially transform treatment methodologies for various diseases.
Collaborations
Rahul has collaborated with talented individuals such as Alka Dwivedi and Atharva Karulkar. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.
Conclusion
In summary, Rahul Purwar's contributions to immunotherapy through his innovative patent and collaborative efforts highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical treatments.